LYCA

33.0704.09%
AW

Aetna Wun Trombley

CEO, Secretary, President & Director

Dr. Aetna Wun Trombley, Ph.D., has been Chief Executive Officer, President and Director of Lycia Therapeutics, Inc. since April 2020 and is its Secretary and was its CFO until June 2026. Dr. Trombley served as the Chief Operating Officer of NGM Biopharmaceuticals, Inc. since June 2015 until March 13, 2020 and served as its President since September 2018 until March 13, 2020 and served as its Vice President from 2015 to December 2017. Dr. Trombley served as Vice President of Business Development at NGM Biopharmaceuticals, Inc., served as its Executive Director of Business Development since September 2011 until June 2015. She joined NGM as head of Business Development in 2011. Dr. Trombley joined NGM from Novartis in Basel, Switzerland, where she worked directly for the Chief Executive Officer on key corporate initiatives and strategic projects across its healthcare businesses. Previously, she was an Associate Director of Business Development at XenoPort, Inc. Previously, she served as Chief of Staff for the Chief Executive Officer of Novartis and was a management consultant at McKinsey & Company. Prior to XenoPort, she was a Senior Engagement Manager of McKinsey & Company, where she advised pharmaceutical and medical device clients on strategic, commercial and operational issues. She has been a Director of Carmot Therapeutics, Inc. from May 2016 to January 2024. She received a B.S. in Chemistry from the University of California, San Diego and a Ph.D. in Chemistry from Massachusetts Institute of Technology.

Positions